FDA May Ask Congress For Funds To Boost Translational Research For Drugs
Executive Summary
FDA is understood to be considering whether legislation could be useful to help promote translational research for pharmaceuticals
You may also be interested in...
Cancer Drug Development To See “Vast Improvements” In Speed – Thompson
HHS Secretary Thompson vows to make "vast improvements" in expediting oncology drug development using the FDA/National Cancer Institute Interagency Oncology Task Force
Cancer Drug Development To See “Vast Improvements” In Speed – Thompson
HHS Secretary Thompson vows to make "vast improvements" in expediting oncology drug development using the FDA/National Cancer Institute Interagency Oncology Task Force
Abbott To Cut Rx Development Costs In Half By Increasing Candidate Attrition
Abbott believes it can cut the cost of drug development in half by increasing the rate of attrition in the discovery phase, the company said Feb. 9 at a drug development summit sponsored by R&D Directions in Phoenix